American International Group’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-90,030
| Closed | -$3.19M | – | 1254 |
|
|
2024
Q1 | $3.19M | Sell |
90,030
-1,842
| -2% | -$73.7K | 0.01% | 879 |
|
|
2023
Q4 | $4M | Sell |
91,872
-7,913
| -8% | -$311K | 0.02% | 803 |
|
|
2023
Q3 | $3.81M | Sell |
99,785
-7,693
| -7% | -$324K | 0.02% | 781 |
|
|
2023
Q2 | $4.42M | Sell |
107,478
-4,634
| -4% | -$223K | 0.03% | 764 |
|
|
2023
Q1 | $6.44M | Sell |
112,112
-1,050
| -0.9% | -$59.2K | 0.04% | 601 |
|
|
2022
Q4 | $6.34M | Sell |
113,162
-1,480
| -1% | -$75.3K | 0.04% | 591 |
|
|
2022
Q3 | $4.86M | Sell |
114,642
-3,494
| -3% | -$179K | 0.04% | 675 |
|
|
2022
Q2 | $6.38M | Sell |
118,136
-5,255
| -4% | -$316K | 0.04% | 593 |
|
|
2022
Q1 | $7.93M | Buy |
123,391
+213
| +0.2% | +$14K | 0.04% | 582 |
|
|
2021
Q4 | $8.25M | Sell |
123,178
-2,090
| -2% | -$141K | 0.04% | 595 |
|
|
2021
Q3 | $8.58M | Sell |
125,268
-913
| -0.7% | -$64.5K | 0.05% | 544 |
|
|
2021
Q2 | $8.61K | Sell |
126,181
-2,259
| -2% | -$160K | 0.03% | 610 |
|
|
2021
Q1 | $8.87K | Buy |
128,440
+699
| +0.5% | +$47.4K | 0.03% | 588 |
|
|
2020
Q4 | $8.29K | Sell |
127,741
-2,015
| -2% | -$108K | 0.03% | 541 |
|
|
2020
Q3 | $6.13M | Sell |
129,756
-1,828
| -1% | -$87K | 0.03% | 575 |
|
|
2020
Q2 | $6.18M | Sell |
131,584
-7,391
| -5% | -$363K | 0.03% | 564 |
|
|
2020
Q1 | $6.21M | Buy |
138,975
+1,438
| +1% | +$75.5K | 0.03% | 477 |
|
|
2019
Q4 | $8.02M | Buy |
137,537
+1,350
| +1% | +$80.4K | 0.03% | 556 |
|
|
2019
Q3 | $8.18M | Sell |
136,187
-2,424
| -2% | -$144K | 0.03% | 514 |
|
|
2019
Q2 | $7.74M | Sell |
138,611
-2,815
| -2% | -$145K | 0.03% | 537 |
|
|
2019
Q1 | $7.88M | Sell |
141,426
-3,021
| -2% | -$154K | 0.03% | 521 |
|
|
2018
Q4 | $6.51M | Buy |
144,447
+439
| +0.3% | +$24.1K | 0.03% | 563 |
|
|
2018
Q3 | $9.49M | Buy |
144,008
+1,684
| +1% | +$105K | 0.03% | 465 |
|
|
2018
Q2 | $9.17M | Buy |
142,324
+101,648
| +250% | +$6.29M | 0.03% | 469 |
|
|
2018
Q1 | $2.25M | Sell |
40,676
-9,905
| -20% | -$519K | 0.01% | 944 |
|
|
2017
Q4 | $2.42M | Buy |
50,581
+1,584
| +3% | +$77.5K | 0.01% | 949 |
|
|
2017
Q3 | $2.47M | Buy |
48,997
+2,994
| +7% | +$154K | 0.01% | 916 |
|
|
2017
Q2 | $2.51M | Buy |
46,003
+9,443
| +26% | +$451K | 0.01% | 908 |
|
|
2017
Q1 | $1.54M | Sell |
36,560
-7,646
| -17% | -$327K | 0.01% | 1008 |
|
|
2016
Q4 | $1.9M | Sell |
44,206
-640
| -1% | -$26K | 0.01% | 956 |
|
|
2016
Q3 | $1.85M | Buy |
44,846
+258
| +0.6% | +$10.8K | 0.01% | 941 |
|
|
2016
Q2 | $1.78M | Sell |
44,588
-24,922
| -36% | -$897K | 0.01% | 945 |
|
|
2016
Q1 | $2.34M | Buy |
69,510
+4,656
| +7% | +$145K | 0.01% | 1057 |
|
|
2015
Q4 | $2.2M | Buy |
64,854
+558
| +0.9% | +$17.4K | 0.01% | 1067 |
|
|
2015
Q3 | $1.92M | Sell |
64,296
-13,140
| -17% | -$411K | 0.01% | 1103 |
|
|
2015
Q2 | $2.13M | Sell |
77,436
-1,639
| -2% | -$43.7K | 0.01% | 1118 |
|
|
2015
Q1 | $1.99M | Buy |
79,075
+306
| +0.4% | +$7.23K | 0.01% | 1173 |
|
|
2014
Q4 | $1.75M | Sell |
78,769
-1,328
| -2% | -$26.9K | 0.01% | 1192 |
|
|
2014
Q3 | $1.63M | Buy |
80,097
+616
| +0.8% | +$12.3K | 0.01% | 1236 |
|
|
2014
Q2 | $1.53M | Buy |
79,481
+2,395
| +3% | +$44.6K | 0.01% | 1279 |
|
|
2014
Q1 | $1.45M | Buy |
77,086
+1,228
| +2% | +$23.7K | 0.01% | 1284 |
|
|
2013
Q4 | $1.48M | Buy |
75,858
+5,615
| +8% | +$103K | 0.01% | 1221 |
|
|
2013
Q3 | $1.16M | Sell |
70,243
-5
| -0% | -$80 | 0.01% | 1317 |
|
|
2013
Q2 | $1.05M | Buy |
+70,248
| New | +$1.03M | 0.01% | 1354 |
|
Other funds holding IART
CB
American International Group's IART Position: Q2 2024 in Review
American International Group sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 90,030 shares — an estimated $3.19M sold.
American International Group first reported a position in IART in Q2 2013 and held it in 44 quarters. The position peaked at $9.49M in Q3 2018. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.
- American International Group reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
- American International Group sold 90,030 Integra LifeSciences shares in Q2 2024, an estimated $3.19M.
- American International Group first reported a position in Integra LifeSciences in Q2 2013 and held it in 44 quarters.
- American International Group's Integra LifeSciences position peaked at $9.49M in Q3 2018.
- 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.